Release of growth hormone from purified somatotrophs: effects of the calcium channel antagonists diltiazem and nifedipine on release induced by growth hormone-releasing factor

Can J Physiol Pharmacol. 1988 Nov;66(11):1373-80. doi: 10.1139/y88-225.

Abstract

We examined the effect of the voltage-sensitive Ca2+ channel antagonists, diltiazem and nifedipine, on basal and stimulated growth hormone (GH) release from purified somatotrophs. Our aim was to ascertain whether an influx of Ca2+ from the extracellular to the intracellular compartment is essential for augmented release. Basal release was decreased in a concentration-dependent manner by both diltiazem and nifedipine, while cAMP accumulation was unaffected. The release of GH induced by 29 mM K+ was blocked by diltiazem and nifedipine, at 10(-7) and 10(-8) M, respectively. Again cAMP was unaffected. The release of GH induced by growth hormone-releasing factor was significantly reduced by 10(-4) M diltiazem and completely blocked by nifedipine at a concentration of 10(-6) M or greater. Where the antagonists were effective, the growth hormone-releasing factor induced increase in cAMP accumulation was augmented. We conclude that an influx of Ca2+ from the extracellular compartment is essential for stimulated GH release.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Diltiazem / pharmacology*
  • Growth Hormone / metabolism*
  • Growth Hormone-Releasing Hormone / metabolism
  • Growth Hormone-Releasing Hormone / pharmacology*
  • Male
  • Nifedipine / pharmacology*
  • Pituitary Gland, Anterior / cytology
  • Pituitary Gland, Anterior / metabolism*
  • Radioimmunoassay
  • Rats
  • Rats, Inbred Strains

Substances

  • Growth Hormone
  • Growth Hormone-Releasing Hormone
  • Cyclic AMP
  • Diltiazem
  • Nifedipine